Skip to main content
Clinical Trials/NCT06180291
NCT06180291
Recruiting
N/A

Impact of a Screening and Early Intervention Program on the Functional Impact of Cerebral Palsy at 2 Years in Children at High Risk of Cerebral Palsy: a Prospective Comparative Multicenter Study.

Hospices Civils de Lyon16 sites in 1 country66 target enrollmentMarch 14, 2025
ConditionsCerebral Palsy
InterventionsPRECOP program

Overview

Phase
N/A
Intervention
PRECOP program
Conditions
Cerebral Palsy
Sponsor
Hospices Civils de Lyon
Enrollment
66
Locations
16
Primary Endpoint
Score of the Total Motor Index at PDMS-3 scale (Peabody Developmental Motor Scales).
Status
Recruiting
Last Updated
8 days ago

Overview

Brief Summary

Cerebral Palsy (CP) is the most common motor disability in children. It is due to damage that occurs during brain development in the fetus or infant. Early treatment (before 2 years) will allow the child to promote brain plasticity to compensate for the effects of the lesion and reduce the severity of CP. The goals of early intervention are to increase motor, cognitive and communication skills, prevent complications and provide parental support. Most authors agree to recognize the benefit of early care by emphasizing home intervention programs with active parental participation. To date, no recommendations exist in France for the management of cerebral palsy in children under the age of two. It is therefore necessary to conduct scientific studies in this population.

Based on published international studies, the PRECOP program (PREcoce intervention in parent-professional COoperation in Cerebral Palsy) consists of individualized care adapted to the specific needs of each child, from the arrival of the infant at home, by a multidisciplinary team during the child's first two years.

Registry
clinicaltrials.gov
Start Date
March 14, 2025
End Date
September 14, 2029
Last Updated
8 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • New born presenting on transfontanellar ultrasound and confirmed on brain MRI (magnetic resonance imaging) at least one of the following brain lesions at high risk of cerebral palsy :
  • Stage 3 intraventricular hemorrhage, requiring at least 2 subtractive lumbar punctures and/or the establishment of a ventriculoperitoneal bypass
  • Stage 4 intraventricular hemorrhage
  • Periventricular leukomalacia : extensive unilateral or bilateral
  • Sequelae of perinatal anoxo-ischemic encephalopathy
  • Extensive neonatal stroke
  • Less than 3 months old (corrected age in case of prematurity)
  • Hospitalized in neonatology or hospitalized in pediatric intensive care unit or within two months following return home (follow-up visit after initial hospitalization)
  • Affiliate to social security
  • Parental or legal representative consent to participate in the study (free and informed written consent)

Exclusion Criteria

  • Children who have had an Antenatal Diagnosis of a pathology causing fear of the onset of developmental delay
  • Children presenting with a congenital pathology with neonatal revelation, whether of metabolic, genetic or malformative origin
  • Palliative care offered by the neonatology team (LATA: Limitation and Discontinuation of Active Therapeutics)
  • Children participating simultaneously in another screening and early care program (excluding the COCON program (Soins préCOces et COordonnés du Nouveau-né vulnérable))

Arms & Interventions

Intervention group

PRECOP group: screening and early treatment. CAMSP (Centre d'Action Médico-Sociale Précoce) orientation upon discharge from neonatology for immediate follow-up according to PRECOP protocol: early multidisciplinary care, with targeted objectives according to the child's needs.

Intervention: PRECOP program

Control group

Standard of care group: in the control centers, care includes specialized consultations organized by the perinatal network with a hospital and/or community pediatrician belonging to the network until the child is 2 years old. Cerebral palsy screening is based on clinical examination.

Outcomes

Primary Outcomes

Score of the Total Motor Index at PDMS-3 scale (Peabody Developmental Motor Scales).

Time Frame: 24 months

Score of the Total Motor Index at PDMS-3 scale (Peabody Developmental Motor Scales).The Total Motor Index results from the combination of Gross Motor Index and Fine Motor Index scores at PDMS-3. The functional impact of cerebral palsy at 2 years is assessed by the PDMS-3 at 24 months of age will be estimated in each of the two groups by a mean value with a 95% confidence interval.

Secondary Outcomes

  • Cost ratio impact(12, 24 and 36 months)
  • Early relational problems(24 months)
  • Development of Production Language in French (DLPF) questionnaire(24 months)
  • Motor development(24 months)
  • Cognitive development(24 months)
  • Nutritional development(24 months)
  • Parental adherence(through study completion, an average of 42 months)
  • Parental stress(24 months)
  • Implemented intervention and fidelity to the planned intervention at the center level(through study completion, an average of 42 months)
  • Intervention implemented and fidelity to the planned intervention at the patient level(through study completion, an average of 42 months)
  • Program transferability using PIET model: Population, Intervention, Environment, Transfer(through study completion, an average of 42 months)
  • Acceptability of the intervention(through study completion, an average of 42 months)
  • Annual cost impact(12, 24 and 36 months)
  • Budgetary impact(12, 24 and 36 months)

Study Sites (16)

Loading locations...

Similar Trials